Nektar Therapeutics Ratios

Ratios Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 56.98%83.86%69.37%62.52%74.14%85.78%85.22%81.74%90.07%97.95%81.35%87.26%75.57%76.50%58.89%57.28%
EBT Margin -143.60%-24.72%-190.10%-214.63%-108.16%-28.11%-35.50%-93.92%-31.22%57.21%-383.93%-290.32%-514.63%-404.00%-306.54%-121.13%
EBIT Margin -132.25%-17.77%-173.39%-173.91%-80.67%-9.49%-12.73%-68.22%-19.38%57.65%-383.92%-278.00%-437.76%-408.63%-292.59%-106.88%
EBITDA Margin -132.25%-17.77%-173.39%-173.91%-80.67%-9.49%-12.73%-68.22%-19.38%57.65%-383.92%-278.00%-437.76%-408.63%-292.59%-106.88%
Operating Margin -132.25%-17.77%-173.39%-173.91%-80.67%-9.49%-12.73%-68.22%-19.38%57.65%-383.92%-278.00%-437.76%-408.63%-292.59%-106.88%
Net Margin -143.25%-25.28%-191.52%-215.73%-109.66%-27.85%-35.73%-94.52%-31.42%57.09%-384.47%-290.65%-515.27%-407.49%-306.31%-120.89%
FCF Margin 32.46%-54.91%-172.73%-172.85%-28.62%-75.72%-36.52%-74.60%-29.28%58.99%-309.70%-209.62%-419.65%-336.41%-214.68%-180.01%
Efficiency
Inventory Average 9.96M15.46M15.86M13.20M12.15M11.23M10.92M11.05M12.02M13.98M15.55M17.50M17.65M
Assets Average 563.89M552.17M466.16M438.07M470.13M533.76M538.87M1,329.52M2,063.76M1,758.06M1,327.98M913.89M554.32M350.94M
Equity Average 96.51M144.24M122.41M-21.44M-26.79M21.38M47.28M87.98M902.70M1,561.48M1,241.34M878.40M523.07M248.81M95.86M
Invested Capital 102.37M90.66M214.82M47.02M-89.90M36.33M6.43M88.12M87.83M1,717.58M1,658.28M1,077.30M679.51M366.64M130.99M60.74M
Asset Utilization Ratio 0.130.150.320.460.490.310.570.900.060.090.080.100.160.28
Leverage & Solvency
Interest Coverage Ratio -7.81-2.53-12.12-9.12-6.51-1.07-1.61-5.02-2.7031.88-20.65-62.05
Debt to Equity 1.092.66-1.393.4437.602.762.790.140.36
Debt Ratio 0.350.250.290.280.480.430.480.110.25
Equity Ratio 0.170.330.09-0.210.080.010.150.170.800.710.700.610.520.330.20
Times Interest Earned -7.81-2.53-12.12-9.12-6.51-1.07-1.61-5.02-2.7031.88-20.65-62.05
Valuation
Enterprise Value 819.01M896.23M399.05M576.21M1,080.88M1,753.02M1,939.71M1,486.19M9,107.84M4,353.96M2,472.42M1,987.88M1,759.41M-80.20M-195.83M-83.68M
Market Capitalization 868.60M1,212.17M640.22M853.40M1,317.91M1,990.84M2,248.66M1,875.29M9,403.97M5,689.31M3,797.28M3,049.78M2,493.37M424.78M107.79M171.55M
Return Ratios
Return on Sales -1.43%-0.25%-1.92%-2.16%-1.10%-0.28%-0.36%-0.95%-0.31%0.57%-3.84%-2.91%-5.15%-4.07%-3.06%-1.21%
Return on Capital Employed -0.43%-0.30%-0.33%-0.05%-0.07%-0.24%-0.12%0.55%-0.26%-0.26%-0.36%-0.44%-0.52%-0.36%
Return on Invested Capital 0.70%0.76%-1.06%-1.10%
Return on Assets -0.24%-0.32%-0.35%-0.13%-0.18%-0.29%-0.18%0.51%-0.21%-0.25%-0.40%-0.41%-0.50%-0.34%
Return on Equity -0.42%-0.95%-1.43%7.62%2.09%-3.86%-3.31%-1.10%0.75%-0.28%-0.36%-0.60%-0.72%-1.11%-1.24%